Argent BioPharma Limited (RGT.L)

GBp 6.0

(-7.69%)

Net Income Summary of Argent BioPharma Limited

  • Argent BioPharma Limited's latest annual net income in 2023 was -17.53 Million AUD , down -60.45% from previous year.
  • Argent BioPharma Limited's latest quarterly net income in 2023 Q4 was -3.78 Million GBP , up 27.45% from previous quarter.
  • Argent BioPharma Limited reported an annual net income of -10.92 Million AUD in 2022, up 5.28% from previous year.
  • Argent BioPharma Limited reported an annual net income of -11.53 Million AUD in 2021, down -33.75% from previous year.
  • Argent BioPharma Limited reported a quarterly net income of -5.21 Million GBP for 2023 Q2, up 14.92% from previous quarter.
  • Argent BioPharma Limited reported a quarterly net income of -10.92 Million AUD for 2022 FY, up 5.28% from previous quarter.

Annual Net Income Chart of Argent BioPharma Limited (2023 - 2015)

Historical Annual Net Income of Argent BioPharma Limited (2023 - 2015)

Year Net Income Net Income Growth
2023 -17.53 Million AUD -60.45%
2022 -10.92 Million AUD 5.28%
2021 -11.53 Million AUD -33.75%
2020 -8.62 Million AUD 20.07%
2019 -10.78 Million AUD -128.08%
2018 -4.73 Million GBP -2.51%
2017 -4.61 Million GBP 4.04%
2016 -4.8 Million GBP -40.23%
2015 -3.42 Million GBP 0.0%

Peer Net Income Comparison of Argent BioPharma Limited

Name Net Income Net Income Difference